Search
Virtual Second Opinion for IBD Patients Now Available
Now you can schedule a virtual second-opinion consult for any patient with IBD, including Crohn’s disease, ulcerative colitis, pouchitis and IBD-undetermined.Best Practices for Implementing Virtual and Hybrid Cardiac Rehabilitation Programs
In a new study, UCSF researchers found that patients participating in either virtual or hybrid cardiac rehabilitation (CR) programs showed similar improvements in functional capacity to those of in-person CR program participants. Hybrid programs combine in-person and virtual delivery.UCSF Health Performs 150th Robotic Focal HIFU Procedure
UCSF is West Coast leader for the innovative, minimally invasive treatment for prostate cancer patients.Minimally Invasive Skull Base Surgery Center
The role of minimally invasive skull base surgery is expanding in the management and treatment of benign and malignant tumors of the paranasal sinuses, skull base and intracranial compartment.New Hypoparathyroidism Guidelines and Emerging PTH Replacement Therapies for Improved Patient Outcomes
New guidelines from the Second International Workshop on the Evaluation and Management of Hypoparathyroidism provide clinicians with the latest evidence-based recommendations for the prevention, diagnosis and management of this rare disease.Epilepsy Center
The UCSF Epilepsy Center is the Bay Area’s premier level 4 epilepsy center, the highest possible rating from the National Association of Epilepsy Centers.UCSF’s Julie Ann Sosa, MD, Named President-Elect of the American Thyroid Association
Julie Ann Sosa, MD, MA, FACS, endocrine surgeon and chair of the Department of Surgery at UC San Francisco, has been named president-elect of the American Thyroid Association (ATA). She was previously the ATA’s treasurer.CAR-T Cell Therapy Treatment and Research
UCSF is a leader in the newest forms of cellular immunotherapy, which have been shown to be particularly effective in the treatment of B-cell non-Hodgkin lymphoma (NHL) and B-cell acute lymphoblastic leukemia (B-ALL).Electroconvulsive Therapy for Status Epilepticus and a Genetic Diagnosis for Epilepsy and Renal Failure: UCSF Neurohospitalist Cases
One of the first of its kind, the UCSF Neurohospitalist Program specializes in caring for hospitalized patients with complex neurologic disorders.UCSF Clinic Fills Unmet Need for Managing Oral Side Effects of Cancer Therapies
As advances in cancer treatments have expanded, so has the number of side effects that impact the mouth. Oral medicine specialists at UC San Francisco are working to mitigate these often-debilitating problems, which affect the majority of patients undergoing or recovering from cancer therapy.Genomic Sequencing Is Changing Diagnosis, Treatment for Patients with Brain Cancer
Patients diagnosed with a type of brain tumor survived for longer when they were treated aggressively with surgery, radiation and chemotherapy.Could a Drug Prevent Hearing Loss from Loud Music and Aging?
UCSF scientists have achieved a breakthrough in understanding what is happening in the inner ear during hearing loss, laying the groundwork for preventing deafness.Peripheral Artery Disease: Early Intervention, Limb Preservation and Clinical Trials at UCSF
September is Peripheral Artery Disease (PAD) Awareness Month. More than 200 million people worldwide are living with PAD, including more than 20 percent of people age 65 and older.Patients with Intractable Headaches Find Relief at the UCSF Inpatient Headache Unit
UCSF Inpatient Headache Unit treats patients with headache disorders through intravenous infusions of medications such as dihydroergotamine, chlorpromazine and valproate. Patients experiencing frequent and severe migraine, cluster, post-traumatic and other headaches have had their pain alleviated through this service, which is offered by the UCSF Headache Center.Can Reducing Insulin Resistance Minimize Severe Asthma Symptoms?
UCSF researchers led a study that found insulin resistance (IR) is common in patients with severe asthma and is associated with lung function impairment and suboptimal responses to asthma medications.Using AI in Electrocardiogram Analysis Can Improve Diagnosis and Treatment of Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy (HCM) is a leading cause of sudden death in adolescents and initial detection is often difficult. A new UCSF study finds that Artificial Intelligence-enhanced (AI)-Electrocardiograms (ECG) may help identify the condition in its earliest stages and monitor important disease-related changes over time.Seizure Risk Forecasted Days in Advance with Brain Implant Data
Epilepsy ‘weather forecasts’ could let patients plan lives around fluctuations in seizure risk.Center for Encephalitis and Meningitis
The UCSF Center for Encephalitis and Meningitis provides comprehensive services to diagnose and treat patients with challenging neuroinflammatory disorders.UCSF MD Link: Web-Based Communication Portal for Physicians
Our web portal allows referring physicians to securely access their patients’ entire electronic health record, make online referral requests and communicate with our physicians directly and securely.UCSF Study Finds 25% of Patients with HPV+ Oropharynx Cancer May Require Chemoradiotherapy After Robotic Surgery
In a nearly 10-year retrospective study involving 136 carefully selected patients with HPV-positive (HPV+) oropharynx cancer, UC San Francisco researchers found that one in four may meet possible indications for adjuvant chemoradiotherapy following transoral robotic surgery (TORS).UCSF’s Dr. Mitchel Berger on the Cancer Moonshot Relaunch
On Feb. 2, 2022, Mitchel Berger, MD, neurosurgeon and director of the UCSF Brain Tumor Center, attended the relaunch of the White House’s Cancer Moonshot initiative at the invitation of President Joe Biden and Dr. Jill Biden.International Conference Features UCSF Breast Cancer Experts
Breast cancer experts from UCSF Health presented new research and clinical findings at the annual San Antonio Breast Cancer Symposium, the world’s largest and most prestigious breast cancer conference.Research Leads to New Myocarditis Diagnostic and Treatment Strategies
Research conducted by Javid Moslehi, MD, chief of the UCSF Cardio-Oncology and Immunology Program, has led to the discovery of a new form of myocarditis caused by immune checkpoint inhibitors (ICI).New Guidance for Reducing Medication-Related Dementia Risk in Patients With Overactive Bladder
This consensus paper is designed to update urologists and other healthcare providers who prescribe anticholinergics about the risks of these medications and help guide them on when to use anticholinergics and when it is appropriate to use alternatives.